Company Filing History:
Years Active: 2017-2020
Title: Michael Anthony Jankowski: Innovator in Hemostasis Solutions
Introduction
Michael Anthony Jankowski is a prominent inventor based in Newbury, Massachusetts, with significant contributions to the field of medical innovations. As an inventor with two patents under his name, Jankowski has focused on developing methods that enhance the efficacy of treatments related to hemostasis. His work not only illustrates his dedication to advancing medical science but also reflects the collaborative spirit of the industry.
Latest Patents
Jankowski's latest patents include groundbreaking compositions aimed at purifying FXa variant proteins. These patents, titled "Methods for Purifying FXa Variant Proteins" and "FXa Variant Compositions," provide comprehensive solutions comprising recombinant variants of human clotting Factor Xa. These compositions encompass a range of isoforms and post-translational modifications of FXa, which are essential for treating subjects requiring assistance with hemostasis. His innovative approaches significantly contribute to improving therapeutic outcomes in patients.
Career Highlights
Currently, Michael Anthony Jankowski is affiliated with Pfizer Corporation, a leading company in the pharmaceutical industry. His role allows him to work on pioneering projects that have the potential to change the landscape of treatments related to blood coagulation. The expertise he brings to the company underscores the importance of innovation in creating effective medical solutions.
Collaborations
Throughout his career, Jankowski has collaborated with notable colleagues, including Keith A. Johnson and Jason C. Rouse. These partnerships exemplify a team-oriented approach to research and development, enriching the process of invention with diverse insights and expertise. Together, they work towards advancing medical technologies that can improve patient care.
Conclusion
Michael Anthony Jankowski stands out as a notable inventor in the medical field, specifically focusing on innovations pertaining to hemostasis and Factor Xa proteins. His contributions through patents with significant therapeutic implications emphasize the critical role of innovation in healthcare. As Jankowski continues his work with Pfizer Corporation, the medical community eagerly anticipates the potential impact of his inventions on patient treatment and management.